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No exit strategy for lipids
Lipids heading toward lysosomes that carry a mutated ion channel are 
spared from destruction, according to Meidel et al. (page 1477). The ac-
cumulating undigested fat eventually dooms the cell.
Cells get rid of excess fat, which comes from worn-out organelles 
or engulfed pathogens by, for instance, shuttling them in endosomes 
to degradative lysosomes. The two organelles are thought to fuse 
when the lysosomal ion channel TRP-ML1 lets in calcium.
Individuals with mutated TRP-ML1 suffer from a fatal disease 
called mucolipidosis type IV, which is characterized by fat accumulation 
in tissues. The failure of endosomes to fuse with lysosomes in these 
patients’ cells, as seen in previous imaging studies, was thought to 
cause the fat pile up and trigger disease. But because TRP-ML1 also 
lets through protons, which lowers the pH and thus activates lyso-
somal enzymes, Meidel et al. wondered whether the fat backlog is 
caused by a degradation defect 
rather than a fusion failure.
By silencing TRP-ML1 in 
normal cells, the group now shows 
that the channel is not necessary 
for fusion. In its absence, how-
ever, lysosomes became over-
acidified and thus failed to process 
their lipid load. The pH defect 
suggests that the channel leaks 
protons out of the lysosome to 
prevent the interior from becom-
ing too acidic. Lipid-clogged lyso-
somes might send feedback signals 
that prevent them from taking 
on new cargo. 
Retraining macrophages to kill tumors
Some tumors avoid getting killed by turning macrophages into immune-suppressive cells. 
Hagemann et al. (page 1261) now find that these impotent cells can be reverted into weapons 
of tumor destruction by simply suppressing a kinase.
Macrophages can destroy tumor cells by producing inflammatory molecules. But macrophages 
within tumors often secrete harmless antiinflammatory cytokines and proteins that promote tumor 
growth. Tumor cells induce this transformation, but the signals that drive the conversion were unknown.
Hagemann et al. now find that tumor macrophages in mice are disarmed by signals that activate 
NF-κB—a transcription factor that normally drives inflammation. As in inflammation, tumor 
macrophage NF-κB was turned on by IκB kinase (IKK) β. In tumors, however, IKKβ also suppressed 
STAT1—a transcription factor that turns on tumor-fighting genes. The basis for this difference is 
unclear. Perhaps the tumor contains unique cues that instruct the IKK pathway to shut off STAT1.
STAT1 suppression in macrophages depended solely on the cytokine receptor IL-1R and its 
downstream adaptor, MyD88, suggesting that tumors might protect themselves by secreting the IL-1R 
ligand, IL-1β. Macrophages from tumors or from healthy animals became in vivo tumor killers when 
engineered to express dominant-negative IKKβ. These reprogrammed macrophages produced high 
levels of IL-12, which recruited tumor-fighting NK cells. The group is now investigating whether infusing 
similarly reprogramed macrophages into cancer patients will help reverse tumor growth. 
Endothelial cells 
instigate sepsis
During severe bacterial infections, the 
transcription factor NF-κB is both an asset 
and a liability. On page 1303, Ye et al. show 
that its activation in endothelial cells single-
handedly perpetuates the inflammation that 
drives septic shock.
NF-κB is required in endothelial cells for 
new blood vessels to grow. And in immune 
cells, its activation is essential for defense 
against bacteria and other infectious agents. 
Blocking NF-κB in mice, for example, turns a 
normally manageable infection deadly. But 
more selectively inactivating the protein has 
proven beneficial in other systems, including 
certain cancer models.
Following this lead, Ye et al. disabled NF-κB 
activation only in endothelial cells. The resulting 
mice survived a normally lethal bacterial 
infection and avoided septic shock. Being free 
of active NF-κB allowed the endothelial cells 
lining blood vessels to maintain their cell–cell 
junctions and minimize their stickiness, thus 
limiting the fluid leakage and massive immune 
cell infiltration into tissues that triggers shock.
Thus, NF-κB–driven activation of endothelial 
cells, not immune cells, seems to be the driving 
force behind the escalating inflammation that 
causes sepsis. 
Ovarian tumors (blue) are 
destroyed in mice injected with 
macrophages in which IKK𝗃 
signals are inhibited (bottom).
Lysosomes (arrowhead) in TRP-ML1–
deficient cells internalize endosomal 
cargo (spots) but fail to degrade it.